Breaking News Instant updates and real-time market news.

INVH

Invitation Homes

$30.12

0.48 (1.62%)

, ALSN

Allison Transmission

$48.12

0.855 (1.81%)

06:33
11/26/19
11/26
06:33
11/26/19
06:33

BofA/Merrill adds Invitation Homes, Allison Transmission to US 1 List

BofA/Merrill added Invitation Homes (INVH) and Allison Transmission (ALSN) to its US 1 List while removing shares of Equinix (EQIX).

INVH

Invitation Homes

$30.12

0.48 (1.62%)

ALSN

Allison Transmission

$48.12

0.855 (1.81%)

EQIX

Equinix

$553.53

-3.92 (-0.70%)

  • 02

    Dec

  • 03

    Dec

  • 16

    Dec

INVH Invitation Homes
$30.12

0.48 (1.62%)

07/19/19
KBWI
07/19/19
DOWNGRADE
Target $28.5
KBWI
Market Perform
Invitation Homes downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Jade Rahmani downgraded Invitation Homes to Market Perform from Outperform with an unchanged price target of $28.50. The analyst cites valuation for the downgrade.
08/20/19
RBCM
08/20/19
NO CHANGE
Target $30
RBCM
Outperform
Invitation Homes price target raised to $30 from $26 at RBC Capital
RBC Capital analyst Wes Golladay raised his price target on Invitation Homes to $30 and kept his Outperform rating after its Q2 resuls showed a same-store net operating increase of 6.1% thanks to the "favorable supply and demand imbalance". The analyst also notes that the quarter saw a 4% rise in its rent price growth and a 40 bps increase in occupancy, saying that its favorable trends are likely to persist. Golladay further notes that Invitation Homes' turnover has moved lower, which has led to lower "controllable expenses."
10/31/19
BTIG
10/31/19
DOWNGRADE
Target $30
BTIG
Neutral
Invitation Homes downgraded to Neutral from Buy at BTIG
BTIG analyst Ryan Gilbert downgraded Invitation Homes to Neutral from Buy and removed his $30 price target saying shares have achieved his objective at current levels. The analyst said current valuation looks "fair" and expects 2020 growth to moderate more than expected due to increasing competition.
11/08/19
GSCO
11/08/19
INITIATION
Target $29
GSCO
Sell
Invitation Homes initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Richard Skidmore initiated coverage of Invitation Homes with a Sell rating and $29 price target. The analyst started 10 residential real estate investment trusts. Favorable demographic trends, limited disruption threat and strong cash and dividend characteristics drive his positive long-term view of the sector. However, Skidmore forecasts below average funds from operations growth for Invitation through 2022 versus the Residential REIT average.
ALSN Allison Transmission
$48.12

0.855 (1.81%)

11/14/19
11/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Uber (UBER) upgraded to Buy from Hold at Argus with analyst Jim Kelleher saying he believes that the competitive landscape in the company's core Rides and Eats businesses is improving. 2. Stanley Black & Decker (SWK) upgraded to Buy from Underperform at BofA/Merrill with analyst Ross Gilardi saying Stanley has had $350M of annualized run-rate tariff headwind levied against it since the trade war began and any agreement to simply postpone future tariff hikes indefinitely would be positive, while a deal to roll back the September tariff hikes would be "a more important catalyst." 3. Fiverr (FVRR) upgraded to Buy from Neutral at BofA/Merrill with analyst Nat Schindler saying the company's Q3 earnings beat expectations, demonstrating accelerating growth with improving efficiency. 4. Meritor (MTOR) upgraded to Overweight from Sector Weight at KeyBanc. 5. Allison Transmission (ALSN) upgraded to Buy from Neutral at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/19/19
VERT
11/19/19
UPGRADE
VERT
Buy
Allison Transmission upgraded to Buy from Hold at Vertical Research
Vertical Research upgraded Allison Transmission to Buy from Hold.
11/20/19
RAJA
11/20/19
INITIATION
Target $50
RAJA
Outperform
Allison Transmission initiated with an Outperform at Raymond James
Raymond James initiated coverage of Allison Transmission with an Outperform rating and $50 price target.
11/21/19
RAJA
11/21/19
INITIATION
Target $50
RAJA
Outperform
Allison Transmission initiated with an Outperform at Raymond James
Raymond James analyst Felix Boeschen initiated coverage of Allison Transmission with an Outperform rating and $50 price target. In a research note to investors, Boeschen says he suspects Allison's runway for further revenue growth anchored by its push into the Class 8 metro space, Class 4/5 medium duty penetration, and long-term opportunity for global expansion remains largely underappreciated by the Street. While he is cognizant of the long-term risk that electrification could pose to Allison Transmission's legacy on-highway business, with the stock trading at ~8x his 2021 FCF/share estimate, toward the very low end of its 7-16x five- year range, Boeschen says he sees a largely favorable risk/reward skew.
EQIX Equinix
$553.53

-3.92 (-0.70%)

11/04/19
FBNS
11/04/19
NO CHANGE
Target $625
FBNS
Outperform
Equinix price target raised to $625 from $550 at FBN Securities
FBN Securities analyst Shebly Seyrafi raised his price target on Equinix shares to $625 from $550 after the company exceeded the AFFO per share consensus forecast and reported MRR churn that declined on both a yearly and sequential basis and "remains below the key 2.5% level." The analyst, who added that he was "particularly impressed" by the improvement in the company's pricing, keeps an Outperform rating on Equinix shares.
10/31/19
BMOC
10/31/19
NO CHANGE
Target $610
BMOC
Outperform
Equinix price target raised to $610 from $537 at BMO Capital
BMO Capital analyst Ari Klein raised his price target on Equinix to $610 and kept his Outperform rating after its "solid" Q3 results. The analyst notes that the company saw "healthy" bookings in the quarter with "strong" channel activity, adding that its demand trends also remained "positive".
10/31/19
OPCO
10/31/19
NO CHANGE
Target $650
OPCO
Outperform
Equinix price target raised to $650 from $550 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for Equinix (EQIX) to $650 from $550 and maintained an Outperform rating, saying management's tone sounded "more positive" on trends, and gross bookings in Q3 were the highest ever for a third quarter and second-highest ever. The analyst tells investors in a research note that the Interxion (INXN) and Digital Realty (DLR) merger represents and opportunity for Equinix to gain share.
10/31/19
RAJA
10/31/19
NO CHANGE
Target $625
RAJA
Strong Buy
Equinix price target raised to $625 from $560 at Raymond James
Raymond James analyst Frank Louthan, IV raised his price target for Equinix to $625 from $560 and reiterated a Strong Buy rating following the company's quarterly results, saying he continues to believe Equinix represents the best large cap play in its sector, adding that recent M&A validate the model and management continues its strong track record of execution.

TODAY'S FREE FLY STORIES

WFT

Weatherford

$0.00

(0.00%)

18:49
12/13/19
12/13
18:49
12/13/19
18:49
Hot Stocks
Weatherford completes financial restructuring, emerges from Chapter 11 »

Weatherford announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$57.71

-0.81 (-1.38%)

18:40
12/13/19
12/13
18:40
12/13/19
18:40
Hot Stocks
Centene CEO: Our big markets are growing, we're gaining share »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

18:29
12/13/19
12/13
18:29
12/13/19
18:29
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

PLAN

Anaplan

$51.80

1.44 (2.86%)

18:23
12/13/19
12/13
18:23
12/13/19
18:23
Hot Stocks
Anaplan CEO: Digitization has really started to accelerate »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

18:08
12/13/19
12/13
18:08
12/13/19
18:08
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HLIT

Harmonic

$7.94

-0.25 (-3.05%)

17:47
12/13/19
12/13
17:47
12/13/19
17:47
Hot Stocks
Harmonic CFO sells 28K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

17:36
12/13/19
12/13
17:36
12/13/19
17:36
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma up 9.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:33
12/13/19
12/13
17:33
12/13/19
17:33
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin rises 1.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

THMO

ThermoGenesis

$2.88

(0.00%)

17:31
12/13/19
12/13
17:31
12/13/19
17:31
Syndicate
Breaking Syndicate news story on ThermoGenesis »

ThermoGenesis files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:30
12/13/19
12/13
17:30
12/13/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Amarin 

Amarin trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

QTNT

Quotient

$8.60

-0.165 (-1.88%)

17:28
12/13/19
12/13
17:28
12/13/19
17:28
Syndicate
Breaking Syndicate news story on Quotient »

Quotient files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

, GVA

Granite Construction

$26.21

-1.335 (-4.85%)

17:27
12/13/19
12/13
17:27
12/13/19
17:27
Hot Stocks
Breaking Hot Stocks news story on Arrowhead, Granite Construction »

Arrowhead to replace…

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

, SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

17:25
12/13/19
12/13
17:25
12/13/19
17:25
Hot Stocks
Oasis, Southwestern to replace Unit Corp., Frontier in S&P 600 at open on 12/23 »

Oasis Petroleum (OAS) and…

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:24
12/13/19
12/13
17:24
12/13/19
17:24
Hot Stocks
Amarin raises guidance after FDA approves Vascepa »

Amarin (AMRN) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

, LEA

Lear

$129.43

-0.84 (-0.64%)

17:22
12/13/19
12/13
17:22
12/13/19
17:22
Hot Stocks
Grand Canyon, Lear to replace Oasis, Southwestern in S&P 400 at open on 12/23 »

Grand Canyon Education…

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

RTN

Raytheon

$217.31

-0.93 (-0.43%)

17:20
12/13/19
12/13
17:20
12/13/19
17:20
Hot Stocks
Raytheon awarded $123.53M Navy contract modification »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

17:19
12/13/19
12/13
17:19
12/13/19
17:19
Hot Stocks
Live Nation, Zebra Technologies, Steris to move to S&P 500 at open on 12/23 »

Live Nation (LYV), Zebra…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BAESY

BAE Systems

$0.00

(0.00%)

17:15
12/13/19
12/13
17:15
12/13/19
17:15
Hot Stocks
BAE Systems awarded $249.15M Army contract modification »

BAE Systems was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WST

West Pharmaceutical

$146.32

-0.14 (-0.10%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Hot Stocks
West Pharmaceutical announces 848K share repurchase authorization »

On December 10, 2019, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Earnings
Amarin sees FY20 revenue $650M-$700M, consensus $654.55M »

With respect to 2020,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

IBIO

iBio

$0.22

-0.0179 (-7.43%)

17:01
12/13/19
12/13
17:01
12/13/19
17:01
Hot Stocks
iBio receives NYSE noncompliance notice »

iBio, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLT

Applied Therapeutics

$21.23

0.29 (1.38%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Syndicate
Breaking Syndicate news story on Applied Therapeutics »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Earnings
Amarin raises FY19 revenue view to $410M-$425M from $380M-$420M 

FY19 consensus $410.25M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BIO

Bio-Rad

$354.69

-8.005 (-2.21%)

16:56
12/13/19
12/13
16:56
12/13/19
16:56
Hot Stocks
Bio-Rad progressing from ransomware attack recovery detected on Dec 5th »

Bio-Rad Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:50
12/13/19
12/13
16:50
12/13/19
16:50
Hot Stocks
Amarin confirms FDA approval of Vascepa »

Amarin announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.